Atara Biotherapeutics Inc (NAS:ATRA)
$ 10.28 -1.35 (-11.61%) Market Cap: 58.33 Mil Enterprise Value: 83.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Atara Biotherapeutics Inc EBV and MS Day Transcript

Mar 22, 2022 / 08:00PM GMT
Release Date Price: $245.5 (+4.36%)
Operator

Good afternoon, everyone. Thank you for standing by, and welcome to the Atara Biotherapeutics EBV and MS Day Conference Call. (Operator Instructions) There will be 2 question-and-answer sessions during the formal presentation. (Operator Instructions) Please be advised that today's call is being recorded. I'd now like to turn the call over to Eric Hyllengren, Vice President of Investor Relations and Finance at Atara Biotherapeutics. Please go ahead, sir.

Eric Hyllengren
Atara Biotherapeutics, Inc. - VP of IR & Finance

Thank you, operator. Good afternoon, everyone, and welcome to the Atara EBV and MS Day Conference Call. As a reminder, an accompanying slide deck will be available in the Investors & Media section at atarabio.com at the conclusion of this call.

We would like to remind listeners that during the call, the company's management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties associated with the company's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot